Relief for foreign firms amid reports of new Indian pricing panel
This article was originally published in Scrip
Executive Summary
Foreign firms appear to be a relieved lot now that India seems to have put in place a new panel to finalize a mechanism for price negotiations for patented drugs – an issue that's been under deliberation for more than six years now.